Close Menu

NEW YORK (GenomeWeb Daily News) – The US Patent and Trademark Office said yesterday that Under Secretary of Commerce for Intellectual Property and Director David Kappos has signed a final rule rescinding highly controversial regulations that were enacted by the USPTO under the Bush administration and were viewed by many in the biotech industry as hindering their ability to protect IP.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Bloomberg reports AstraZeneca may conduct another study of its candidate SARS-CoV-2 vaccine after dosing error.

Moderna is applying for an Emergency Use Authorization for its coronavirus vaccine, according to the New York Times.

The National Health Service is to conduct a trial of Grail's blood-based screening test for cancer.

In PLOS this week: somatic mutation patterns of glioblastomas among Lebanese patients, phenome-wide study using UK Biobank data, and more.